Month: May 2017

Ecologist loses appeal for whistleblower protection

A top federal U.S. court has confirmed a decision by the National Science Foundation (NSF) to deny federal whistleblower protection to an ecologist who was fired after accusing a colleague of fraud.

After initially forcing NSF to more clearly explain its decision, the Denver-based U.S. Court of Appeals for the 10th Circuit has agreed with the conclusions of NSF’s updated investigation, denying former Kansas State University researcher Joseph Craine’s appeal.

Attorney Paul Thaler, who has handled cases involving scientific misconduct (but was not involved with this one), told Retraction Watch that the latest decision appears to be the end of a cautionary tale of how not to report misconduct.

Continue reading Ecologist loses appeal for whistleblower protection

Announcing the DiRT Award, a new “doing the right thing” prize — and its first recipient

It takes a lot of work to clean up the scientific literature, and some researchers and organizations deserve special recognition. That’s why we’ve established a “doing the right thing” category when we see praise-worthy progress in individual retractions, and have now gone a step further: We’ve created the DiRT Award, a new annual prize to recognize particularly note-worthy behavior.

As our co-founders announce today in STAT, the first recipient of the DiRT Award is the American Diabetes Association (ADA). Regular readers may suspect why — here’ a hint — but to learn more about the award, and why it’s going to the ADA, check out our co-founders’ STAT column out today. Continue reading Announcing the DiRT Award, a new “doing the right thing” prize — and its first recipient

After researcher is convicted of sexual assault, journal retracts her co-author’s paper

A disability journal has retracted a paper supposedly penned by a man with severe disabilities, citing duplication.

Although the reason for the retraction may sound run-of-the-mill, this situation is far from ordinary.

The author, known as DMan Johnson — or simply “D.J.” — has cerebral palsy, and was communicating using a controversial technique called “facilitated communication” with Anna Stubblefield, the former chairwoman of philosophy at Rutgers University. In October 2015, Stubblefield was convicted of sexually assaulting D.J., who has been diagnosed with spastic quadriplegia and severe mental retardation. The following month, she was sentenced to 12 years in prison.

In October 2015, Disability Studies Quarterly issued a statement that it was taking a second look at papers by Stubblefield, but did not specify which ones.

Continue reading After researcher is convicted of sexual assault, journal retracts her co-author’s paper

Publisher backs down in dispute with society over journal name

What do Kentucky Fried Chicken and scientific publishing have in common?

Last month, the fast food chain objected to the use of the phrase “Finger Lakin’ Good” by a man in New York, claiming the phrase was too similar to KFC’s familiar “Finger Lickin’ Good” motto.

This week, the American College of Rheumatology (ACR) forced an alleged predatory publisher to change the name of one of its journals that the society felt — fairly, it seems — was too close for comfort to one of its main titles.

In an email earlier this week, the ACR warned authors about the existence of the Journal of Arthritis and Rheumatology, a new open-access publication whose name is sometimes shortened to Arthritis and Rheumatology. To the ACR, that sounds an awful lot like the group’s own Arthritis & Rheumatology, which is published by Wiley.

Per the letter: Continue reading Publisher backs down in dispute with society over journal name

Updated: Science fish-microplastics paper retracted

Despite continuing to vigorously defend their work, the authors of a controversial paper about the effects of human pollution asked Science to retract the paper last week.

According to a release from Uppsala University issued today, authors Peter Eklöv and Oona Lönnstedt submitted their request to Science last week, noting they wanted to withdraw the paper “as long as a suspicion of misconduct remains.”

The release — which echoes a statement that was also provided to Nature — notes:

Continue reading Updated: Science fish-microplastics paper retracted

Researcher who sued to prevent retractions now has 12

A diabetes researcher who once sued a publisher to prevent several retractions has just issued his 12th.

The latest retraction, like several others for Mario Saad, appears in the journal Diabetes. Although in the past Saad expended considerable effort to protect four other Diabetes papers from this same fate, the latest retraction was initiated by the authors, citing several duplicated images. The American Diabetes Association had flagged the 2009 paper with an expression of concern earlier this year.

In 2015, Saad brought a lawsuit against the ADA, claiming that it “wrongfully published” four expressions of concerns in its flagship journal Diabetes, in an attempt to prevent the papers from being retracted. He lost, and the papers were retracted in 2016.

The lawsuit also did nothing to deter the ADA from flagging other potentially problematic papers with expressions of concerns, including the latest 2009 Diabetes paper, on which Saad is last and corresponding author.  Continue reading Researcher who sued to prevent retractions now has 12

PLOS upgrades flag on controversial PACE chronic fatigue syndrome trial; authors “surprised”

PLOS ONE has issued an expression of concern after the authors of a controversial study about chronic fatigue syndrome declined to share some of their data.

In an unusual move, the journal included the authors’ response to the expression of concern (EOC), in which they strongly argue against the notice, and “do not accept that it is justified.”

In 2015, following public requests to review the data, the journal issued an “editor’s note” on the paper, noting the journal’s policy that authors make data and materials available.

There have been numerous requests for data from the “PACE” trial, as the clinical trial is known. Patients and advocates have long disputed the results, arguing that suggesting cognitive behavior and graded exercise therapy could cause harm.

In the latest notice, the journal says it consulted two editorial board members about the paper, a 2012 sub analysis of a controversial clinical trial on chronic fatigue syndrome. The journal then asked the authors to provide the data behind five tables, which would enable researchers to replicate the cost-effectiveness analyses the authors report for different therapies — including graded exercise therapy, which some patient advocates believe could be harmful.

As with previous requests for data, the authors refused to provide it, citing patient confidentiality and consent. The notice explains:

Continue reading PLOS upgrades flag on controversial PACE chronic fatigue syndrome trial; authors “surprised”

Author objects to retraction after he says journal ignored his queries for three years

In 2014, a journal contacted researcher Denis Rousseau about one of his papers that had just been published online ahead of print, raising some concerns. According to Rousseau, he sent the journal a corrected figure “almost immediately,” which he believed addressed the issue.

Rousseau, a cell biologist at the University Joseph Fourier in Grenoble, France, said he then contacted the journal many times over the next three years to ask about the status of the paper — which never ended up in print — but heard nothing back.

Three years passed.

In March, the publisher finally contacted Rousseau, this time to ask him to issue a formal retraction for the paper. And despite his objections, Molecular and Cellular Biology published a sparse retraction notice, which provides little information about what went wrong:

Continue reading Author objects to retraction after he says journal ignored his queries for three years

Peer review in 2030: New report hopes it’s faster, more transparent, and more diverse

Elizabeth Moylan
Rachel Burley

Over the decades, the concept of peer review has changed dramatically – so what does the future hold? That’s a question examined in a new report issued today by BioMed Central and Digital Science, based on discussions held during the SpotOn London conference. (Disclosure: Our co-founder Ivan Oransky spoke there.) We spoke with Elizabeth Moylan, Senior Editor Research Integrity at BioMed Central, and Rachel Burley, Publishing Director at BioMed Central about the central question posed by the report: What will peer review look like in the year 2030?

Retraction Watch: People have many complaints about peer review. What do you think are its most pressing flaws?

Continue reading Peer review in 2030: New report hopes it’s faster, more transparent, and more diverse

“Remarkable” it was ever accepted, says report: Science to retract study on fish and microplastics

Science is retracting a paper about how human pollution is harming fish, after months of questions about the validity of the data.

The move, first reported by the news side of Science on Friday, follows a new report from a review board in Sweden that concluded the authors were guilty of “scientific dishonesty,” and the paper should be “recalled.”

The report had some strong words for the journal and the university that conducted a preliminary investigation:

Continue reading “Remarkable” it was ever accepted, says report: Science to retract study on fish and microplastics